A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read More
Breath-based VOC analysis could give clinical labs a faster, noninvasive way to assess gut microbiome health and detect disease earlier.
The landscape of clinical diagnostics is on the cusp of a significant transformation, with new research pointing towards a rapid,…
Read More
Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization
Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
The United States’ withdrawal from the World Health Organization (WHO) and proposed changes to vaccine mandates have ignited significant debate…
Read More
How Clinical Laboratories Can Prepare for Crisis Events Before They Happen
Clinical laboratories, the silent sentinels of public health, operate at the nexus of patient care and scientific precision. Yet, this…
Read More
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
This groundbreaking research from the Johns Hopkins Kimmel Cancer Center heralds a new era in early cancer detection, introducing a…
Read More
Executive War College 2026 to Spotlight AI, Workforce Solutions, and Financial Strategy for Clinical Labs
New Orleans is poised to host the 31st Annual Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management from…
Read More
TWiV 1284: Clinical update with Dr. Daniel Griffin
In a post-New Year’s Day recording, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) provided a…
Read More
LinkedIn Report Unveils Critical Skills Driving the Future of Clinical Laboratory Careers Amidst Evolving Healthcare Landscape
A groundbreaking analysis from LinkedIn’s latest "Skills on the Rise" report has cast a revealing light on the rapidly transforming…
Read More
Daiichi Sankyo and Tempus AI collaborate on ADC clinical development
In a significant move poised to accelerate the innovation pipeline for antibody-drug conjugate (ADC) therapies, Japanese pharmaceutical giant Daiichi Sankyo…
Read More
